ResearcherTokyo Medical UniversityNo recent work listed
Yuichi Hosokawa
Matched on OpenAlex author ID A5110804329. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2014: 1 paper · 2015: none · 2016: 1 paper · 2017: 2 papers · 2018: 2 papers · 2019: 1 paper · 2020: 1 paper
Papers 8
- Clinical impact of pancreaticoduodenectomy for pancreatic cancer with resection of the secondary or later branches of the superior mesenteric vein. Co-author DOI 10.1002/jhbp.789↗
- Clinical Impact of Neoadjuvant Chemotherapy and Chemoradiotherapy in Borderline Resectable Pancreatic Cancer: Analysis of 884 Patients at Facilities Specializi… Co-author DOI 10.1245/s10434-018-07131-8↗
- Surgical Outcomes of Pancreaticoduodenectomy for Pancreatic Cancer with Proximal Dorsal Jejunal Vein Involvement. Co-author DOI 10.1007/s11605-018-3722-0↗
- Irreversible Electroporation for Nonthermal Tumor Ablation in Patients with Locally Advanced Pancreatic Cancer: Initial Clinical Experience in Japan. Co-author DOI 10.2169/internalmedicine.0861-18↗
- A phase II trial of neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy combined with gemcitabine and S-1 for borderline-resectable pancreatic … First author DOI 10.1007/s00280-017-3288-7↗
- Serum SPan-1 Is a Significant Risk Factor for Early Recurrence of Pancreatic Cancer after Curative Resection. Co-author DOI 10.1159/000449041↗
- Feasibility of intensity-modulated radiotherapy combined with gemcitabine and S-1 for patients with pancreatic cancer. Co-author DOI 10.3892/mco.2015.664↗
- Pancreaticoduodenectomy with right-oblique posterior dissection of superior mesenteric nerve plexus is logical procedure for pancreatic cancer with extrapancre… First author PMID 25699385↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yuichi Nagakawa · 8 shared papers, 2014–2020 · strength 0.59
- Paper Clinical impact of pancreaticoduodenectomy for pancreatic cancer with resection of the secondary or later branches of t… DOI 10.1002/jhbp.789↗
- Paper Irreversible Electroporation for Nonthermal Tumor Ablation in Patients with Locally Advanced Pancreatic Cancer: Initial… DOI 10.2169/internalmedicine.0861-18↗
- Paper Serum SPan-1 Is a Significant Risk Factor for Early Recurrence of Pancreatic Cancer after Curative Resection. DOI 10.1159/000449041↗
- Akihiko Tsuchida · 8 shared papers, 2014–2020 · strength 0.59
- Paper Clinical impact of pancreaticoduodenectomy for pancreatic cancer with resection of the secondary or later branches of t… DOI 10.1002/jhbp.789↗
- Paper Irreversible Electroporation for Nonthermal Tumor Ablation in Patients with Locally Advanced Pancreatic Cancer: Initial… DOI 10.2169/internalmedicine.0861-18↗
- Paper Serum SPan-1 Is a Significant Risk Factor for Early Recurrence of Pancreatic Cancer after Curative Resection. DOI 10.1159/000449041↗
- Takao Itoi · 2 shared papers, 2018 · strength 0.15
- Paper Irreversible Electroporation for Nonthermal Tumor Ablation in Patients with Locally Advanced Pancreatic Cancer: Initial… DOI 10.2169/internalmedicine.0861-18↗
- Paper Surgical Outcomes of Pancreaticoduodenectomy for Pancreatic Cancer with Proximal Dorsal Jejunal Vein Involvement. DOI 10.1007/s11605-018-3722-0↗
- Koichi Tokuuye · 2 shared papers, 2016–2017 · strength 0.12
- Paper A phase II trial of neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy combined with gemcitabine and S… DOI 10.1007/s00280-017-3288-7↗
- Paper Feasibility of intensity-modulated radiotherapy combined with gemcitabine and S-1 for patients with pancreatic cancer. DOI 10.3892/mco.2015.664↗
- Masayuki Honda · 1 shared paper, 2020 · strength 0.12
- Masanori Akashi · 1 shared paper, 2020 · strength 0.12
- Hitoe Nishino · 1 shared paper, 2020 · strength 0.12
- Kazuhiko Kasuya · 2 shared papers, 2014–2017 · strength 0.10
- Katsutoshi Sugimoto · 1 shared paper, 2018 · strength 0.09
- Fuminori Moriyasu · 1 shared paper, 2018 · strength 0.09
- Yoshiaki Murakami · 1 shared paper, 2019 · strength 0.07
- Sohei Satoi · 1 shared paper, 2019 · strength 0.07
- Shuji Isaji · 1 shared paper, 2019 · strength 0.07
- Shigeyuki Kawachi · 1 shared paper, 2019 · strength 0.07
- Tetsuo Ohta · 1 shared paper, 2019 · strength 0.07
- Masayuki Sho · 1 shared paper, 2019 · strength 0.07
- Hiroki Yamaue · 1 shared paper, 2019 · strength 0.07
- Shuji Suzuki · 1 shared paper, 2019 · strength 0.07
- Michiaki Unno · 1 shared paper, 2019 · strength 0.07
- Tsutomu Fujii · 1 shared paper, 2019 · strength 0.07
- Itaru Endo · 1 shared paper, 2019 · strength 0.07
- Atsushi Sofuni · 1 shared paper, 2018 · strength 0.07
- Norifumi Kennoki · 1 shared paper, 2016 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.